民主党参议员敦促联邦政府重新安排大麻

2024-08-06 01:44

A group of Democratic senators, including Majority Leader Chuck Schumer (N.Y.), are urging the heads of the Justice Department and Drug Enforcement Agency to go ahead with a proposal to reschedule marijuana to a Schedule III drug from a Schedule I.
The senators, which also include Finance Committee Chair Ron Wyden (Ore.) and Cory Booker (N.J.), sent a letter Aug 2 to Attorney General Merrick Garland and DEA Administrator Anne Milgram.
The rescheduling, which is backed by HHS, "recognizes the medical benefits of marijuana, will improve access for studying the health effects of short and long-term cannabis use, and will provide relief to cannabis businesses that continue to navigate a patchwork regulatory system to conduct legal business," the senators argue.
They noted that rescheduling "bolsters cannabis related businesses" and "will reduce burdensome restrictions on the safe and regulated of cannabis use by clinicians and scientific professionals."
The group added that "cannabis should be entirely descheduled."
Multi-state operators: Ascend Wellness (OTCQX:AAWH), Curaleaf Holdings (OTCPK:CURLF), Cresco Labs (OTCQX:CRLBF), Green Thumb Industries (OTCQX:GTBIF), Trulieve Cannabis (OTCQX:TCNNF), Ayr Wellness (OTCQX:AYRWF), Verano Holdings (OTCQX:VRNOF), and Jushi Holdings (OTCQX:JUSHF).
Cannabis ETFs: AdvisorShares Pure Cannabis ETF (YOLO), Amplify Alternative Harvest ETF (NYSEARCA:MJ), and Amplify Seymour Cannabis ETF (CNBS).

More on cannabis reform